Mason Street Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-172,921
| Closed | -$10.1M | – | 485 |
|
|
2020
Q4 | $10.1M | Sell |
172,921
-3,167
| -2% | -$191K | 0.17% | 105 |
|
|
2020
Q3 | $11.1M | Sell |
176,088
-2,938
| -2% | -$204K | 0.22% | 79 |
|
|
2020
Q2 | $13.8M | Sell |
179,026
-1,481
| -0.8% | -$114K | 0.28% | 66 |
|
|
2020
Q1 | $13.5M | Hold |
180,507
| – | – | 0.31% | 60 |
|
|
2019
Q4 | $11.7M | Buy |
180,507
+78
| +0% | +$5.08K | 0.22% | 77 |
|
|
2019
Q3 | $11.4M | Sell |
180,429
-917
| -0.5% | -$59.9K | 0.24% | 76 |
|
|
2019
Q2 | $12.3M | Sell |
181,346
-622
| -0.3% | -$40.9K | 0.26% | 70 |
|
|
2019
Q1 | $11.8M | Sell |
181,968
-413
| -0.2% | -$27.4K | 0.24% | 77 |
|
|
2018
Q4 | $11.4M | Buy |
182,381
+143
| +0.1% | +$9.99K | 0.28% | 68 |
|
|
2018
Q3 | $14.1M | Sell |
182,238
-192
| -0.1% | -$14.5K | 0.29% | 65 |
|
|
2018
Q2 | $12.9M | Sell |
182,430
-45
| -0% | -$3.18K | 0.28% | 63 |
|
|
2018
Q1 | $13.8M | Buy |
182,475
+523
| +0.3% | +$41.6K | 0.31% | 57 |
|
|
2017
Q4 | $13M | Buy |
181,952
+665
| +0.4% | +$50.5K | 0.29% | 61 |
|
|
2017
Q3 | $14.7M | Sell |
181,287
-72
| -0% | -$5.51K | 0.35% | 51 |
|
|
2017
Q2 | $12.8M | Buy |
181,359
+732
| +0.4% | +$48.7K | 0.32% | 49 |
|
|
2017
Q1 | $12.3M | Buy |
180,627
+405
| +0.2% | +$28.5K | 0.32% | 51 |
|
|
2016
Q4 | $12.9M | Buy |
180,222
+1,700
| +1% | +$126K | 0.35% | 48 |
|
|
2016
Q3 | $14.1M | Sell |
178,522
-866
| -0.5% | -$70.3K | 0.4% | 40 |
|
|
2016
Q2 | $15M | Sell |
179,388
-2,678
| -1% | -$238K | 0.44% | 42 |
|
|
2016
Q1 | $16.7M | Sell |
182,066
-6,209
| -3% | -$560K | 0.51% | 32 |
|
|
2015
Q4 | $19.1M | Sell |
188,275
-1,612
| -0.8% | -$168K | 0.6% | 26 |
|
|
2015
Q3 | $18.6M | Buy |
189,887
+654
| +0.3% | +$72.6K | 0.63% | 22 |
|
|
2015
Q2 | $22.2M | Sell |
189,233
-2,579
| -1% | -$282K | 0.68% | 20 |
|
|
2015
Q1 | $18.8M | Sell |
191,812
-335,224
| -64% | -$34M | 0.57% | 26 |
|
|
2014
Q4 | $49.7M | Sell |
527,036
-148,842
| -22% | -$15.4M | 0.35% | 40 |
|
|
2014
Q3 | $71.9M | Sell |
675,878
-85,074
| -11% | -$8.33M | 0.56% | 17 |
|
|
2014
Q2 | $63.1M | Sell |
760,952
-109,556
| -13% | -$8.53M | 0.49% | 25 |
|
|
2014
Q1 | $61.7M | Buy |
870,508
+59,582
| +7% | +$4.67M | 0.5% | 22 |
|
|
2013
Q4 | $60.9M | Buy |
810,926
+256,026
| +46% | +$17.8M | 0.5% | 21 |
|
|
2013
Q3 | $34.9M | Sell |
554,900
-221,450
| -29% | -$13.2M | 0.4% | 45 |
|
|
2013
Q2 | $39.8M | Buy |
+776,350
| New | +$40.5M | 0.44% | 41 |
|
Other funds holding GILD
Mason Street Advisors's GILD Position: Q1 2021 in Review
Mason Street Advisors sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 172,921 shares — an estimated $10.1M sold.
Mason Street Advisors first reported a position in GILD in Q2 2013 and held it in 31 quarters. The position peaked at $71.9M in Q3 2014. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.
- Mason Street Advisors reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 172,921 Gilead Sciences shares in Q1 2021, an estimated $10.1M.
- Mason Street Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Gilead Sciences position peaked at $71.9M in Q3 2014.
- 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.